TriaGen Wealth Management’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
JSP
TriaGen Wealth Management's ACLS Position: Q1 2024 in Review
TriaGen Wealth Management sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 3,812 shares — an estimated $494K sold.
TriaGen Wealth Management first reported a position in ACLS in Q1 2022 and held it in 3 quarters. The position peaked at $494K in Q4 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.
- TriaGen Wealth Management reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
- TriaGen Wealth Management sold 3,812 Axcelis shares in Q1 2024, an estimated $494K.
- TriaGen Wealth Management first reported a position in Axcelis in Q1 2022 and held it in 3 quarters.
- TriaGen Wealth Management's Axcelis position peaked at $494K in Q4 2023.
- 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.
Based on TriaGen Wealth Management's 13F filing for Q1 2024, filed 23 Apr 2024.